LCM
CCCC icon

Lynx1 Capital Management’s C4 Therapeutics CCCC Stock Holding History

Lynx1 Capital Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Sell
6,998,902
-99,231
-1% -$234K 2.91% 6
2025
Q4 		$13.6M Hold
7,098,133
– – 2.74% 5
2025
Q3 		$15.8M Hold
7,098,133
– – 3.21% 6
2025
Q2 		$10.2M Hold
7,098,133
– – 2.93% 8
2025
Q1 		$11.4M Buy
7,098,133
+245,389
+4% +$732K 4.07% 7
2024
Q4 		$24.7M Sell
6,852,744
-27,783
-0.4% -$138K 9.25% 4
2024
Q3 		$39.2M Hold
6,880,527
– – 13.9% 3
2024
Q2 		$31.8M Buy
6,880,527
+3,245,865
+89% +$19.4M 11.47% 4
2024
Q1 		$29.7M Buy
3,634,662
+500,266
+16% +$3.88M 7.65% 7
2023
Q4 		$17.7M Buy
3,134,396
+2,115,166
+208% +$4.82M 6.96% 5
2023
Q3 		$1.9M Buy
+1,019,230
New +$3.11M 1.25% 13

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return